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Adverse effects associated with smoking during pregnancy are
well documented. Although self-report surveys on drug consump-
tion during pregnancy have been improved with new interviewing
techniques, underreporting is still a concern. Therefore, a series of
biological markers and specimens to diagnose fetal exposure to
tobacco have been studied. In the present study, an analytical
method was developed to detect nicotine and cotinine (the main
nicotine metabolite) in meconium samples. Accelerated solvent ex-
traction (ASE) followed by solid-phase extraction (SPE) were used
as sample preparation techniques. The analytes were detected by
gas-chromatography with nitrogen-phosphorus detection. The limits
of detection were 3.0 and 30 ng/g for cotinine and nicotine, re-
spectively. The method showed good linearity (r2 > 0.98) in the con-
centration range studied (LOQ–500 ng/g). The intraday precision,
given by the RSD of the method, was less than 15% for cotinine and
nicotine. The method proved to be fast, practical, and sensitive.
Smaller volumes of organic solvents are necessary compared to
other chromatographic methods published in the scientific literature.
This is the first report in which ASE was used as sample preparation
technique in methods to detect xenobiotics in meconium.
Introduction
Tobacco is one of the main drugs consumed worldwide, and
its use by women of childbearing age has played a major
concern among experts and society in general. Although the
dose and frequency that could affect the child before birth are
unknown, information about the harmful effects of fetal expos-
ure to tobacco constituents is widely disseminated (1). In fact,
many addicted women continue tobacco use during pregnancy
despite known adverse consequences on neonatal growth and
development (2). Nicotine, carbon monoxide, and other toxic
constituents of tobacco smoke can cause direct adverse effects
on oxygen supply to the fetus, structure and function of the um-
bilical cord and placenta, fetal heart rate, and fetal breathing (3).
Adverse effects associated with smoking during pregnancy
include ectopic pregnancy, spontaneous abortion, prematurity,
low birth weight, fetal growth restriction, preterm delivery,
orofacial clefts, sudden infant death syndrome, craniosynostosis,
clubfoot, childhood respiratory disease, attention deﬁcit dis-
order, and some childhood cancers (4–9).
As a ﬁrst attempt to identify smoking during pregnancy, ma-
ternal self-reports are widely used. However, maternal reports
regarding smoking are sometimes unreliable. Many women
underreport their smoking habits during pregnancy because of
social pressure, guilt, or embarrassment (5, 7). Therefore, an ac-
curate identiﬁcation of children exposed in utero to tobacco is
sorely needed to better assess the source and the proportion
of effects. Clinical treatment and follow-up performed in chil-
dren exposed could be more suitable if an efﬁcacious identiﬁ-
cation of fetal exposure was conducted (10).
Identifying nicotine biomarkers in biological specimens pro-
vides an alternative method to self-reported gestational tobacco
use. In recent years, toxicological analysis of meconium (the
ﬁrst neonatal feces) has shown particular promise in the evalu-
ation of fetal exposure to psychoactive substances. The deter-
mination of nicotine and its biotransformation products, such
as cotinine, in meconium have been proposed as possible bio-
logical markers for the assessment of long-term fetal tobacco
exposure (11, 12). In spite of the many methods that have
already been published for illicit and therapeutic drugs, few
procedures exist for nicotine and metabolite analysis of meco-
nium samples, perhaps because of its complex composition
and analytical challenges (13).
The chromatographic methods for identiﬁcation of nicotine
biomarkers in meconium samples are generally based on time-
consuming and laborious procedures involving homogenization of
the samples with solvents and followed by centrifugation, prior
to the solid-phase extraction procedure (SPE) for puriﬁcation
of analytes, with or without a hydrolysis step (6, 13, 14).
Accelerated solvent extraction (ASE), a relatively new tech-
nique, has gained considerable interest in several areas, especial-
ly in the analysis of substances in complex matrices, such as
environmental samples (e.g., soil, sediment, and sewage sludge),
different kinds of food (15), and some biological samples, such
as feces (16). ASE combines the temperature and pressure in-
crease with organic solvents to improve the efﬁciency of the ex-
traction process compared with conventional techniques.
Samples (solid or semi-solid) are placed in an extraction cell,
made of stainless steel, which in turn is subjected to the passage
of pressurized solvent while the system is heated. The design of
the extractor, capable of withstanding high pressures, allows the
extraction temperature to be raised above the boiling point of
the solvent used. The increased temperature accelerates the ex-
traction kinetics, and high pressure keeps the solvent in liquid
form during the process. Under these conditions, the solvent
has properties that can improve the extraction process, such as
low viscosity, high diffusion coefﬁcients, and high solvent
strength. When the extraction is complete, compressed nitrogen
moves all of the solvent from the cell to the vial for analysis. The
equipment provides precise control of temperature and pres-
sure, allowing equality in the extraction of cells in different se-
quence analysis. The technique also combines automated
extraction and ﬁltration in a single process and generally uses
less solvent than conventional extraction techniques (16, 17).
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The aim of the current study was to develop a gas chromato-
graphic (GC) method for the determination of nicotine and coti-
nine in meconium samples, using accelerated solvent extraction
as sample preparation technique. As far as we know, this is the
ﬁrst study in which accelerated solvent extraction was used in a
method to detect xenobiotics in meconium samples.
Materials and Methods
Reagents and materials
Standard solutions of nicotine and cotinine (1.0 mg/mL in
methanol) were obtained from Cerilliant (Round Rock, TX).
The internal standard, prolintane, was prepared at the initial
concentration of 1.0 mg/mL by dissolving in methanol the
powder obtained from Boehringer Ingelheim (Ingelheim,
Germany). Their chemical structures are shown in Figure 1. All
other reagents were obtained from Merck (Darmstadt,
Germany). Diatomaceous earth, used as inert material to ﬁll the
ASE cell extraction, was purchased from Dionex (Sunnyvale,
CA). SPE cartridges (Bond-Elut Certify 3 mL/130 mg) were
obtained from Varian (Harbor City, CA).
Preparation of standard solutions
Working solutions of the nicotine, cotinine and prolintane at
concentrations of 1.0 and 10 mg/mL were prepared in metha-
nol in volumetric glassware. Stock solutions were stored at
–208C when not in use.
Instrumentation
Accelerated solvent extraction equipment (ASEw 100
Accelerated Solvent Extractor) was obtained from Dionex. GC
analyses for nicotine and cotinine were performed using a GC
equipped with a nitrogen-phosphorus detector (GC–NPD)
(model Agilent 6890N, Palo Alto, CA) and autosampler (model
Agilent 7683). Chromatographic separation was achieved on an
HP-5 fused-silica capillary column (30 m  0.25 mm  0.1-mm
ﬁlm thickness). The injections were made in splitless mode.
Nitrogen was used as carrier gas in a constant ﬂow of 1.2 mL/
min. The injector and detector temperatures were 2008C and
2508C, respectively. The oven temperature was initially held at
1008C for 1 min and programmed to increase by 108C/min to
2008C held for 4 min. The chromatographic total run time was
15 min. The injection volume was 1.0 mL.
Meconium samples
Meconium samples were collected from neonates born in
University Hospital, Sa˜o Paulo (HU-USP). The material was col-
lected from diapers and pooled into one plastic container per
infant. Samples were immediately stored at –08C until analysis.
This study was approved by the College of Pharmaceutical
Sciences Ethics Committee, University of Sa˜o Paulo. Informed
consent was obtained from the mother in each case (Ethics
Protocol Approval no. CEP 723/07).
Preparation of meconium samples
Meconium samples (500+10 mg) were combined with 10 mL
of standard solution prolintane at a concentration of 10 mg/mL.
Figure 1. Chemical structures of nicotine, cotinine, and prolintane (internal
standard).
Figure 2. Optimization of ASE technique. All results are expressed as average of
absolute area. Influence of the number of cycles in ASE extraction efficiency
(A); influence of the temperature on the extraction yield using solvent phosphate
buffer 0.1 M (pH 6.0) (B); and influence of the temperature on the extraction yield
using solvent hexane/acetone (1:1) (C).
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Afterwards, approximately 2.4 g of diatomaceous earth was
used to ﬁll the 10-mL cell extraction that was further attached
to the equipment. The procedure of ASE is initiated by passing
the solvent (0.1 M phosphate buffer, pH 6.0) through the
sample cell under controlled pressure (1500 psi) and tempera-
ture (1208C). The conditions of extraction were as follows:
5 min to warm up, 3 min of static cycle, and 1 min of purging.
The collection tube was placed in the exit of ASE system and
about 10 mL of the aqueous extract was collected. The extract
was submitted to a subsequent SPE procedure. Bond-Elut
Certify cartridge was conditioned with 3 mL methanol and
3 mL of 0.1 M phosphate buffer (pH 6.0). The extract obtained
from ASE was loaded and allowed to ﬂow under vacuum (one
drop/s). The cartridge was washed out with 2  3 mL of deio-
nized water, followed by 3 mL of 0.1 M HCl, and 3  3 mL of
methanol. The analytes were eluted with 2 mL of freshly pre-
pared dichloromethane/isopropanol/ammonium hydroxide
(12:3:0.3). The eluate was evaporated under a ﬂow of N2 at
408C. The residue was reconstituted by dissolving in 50 mL
methanol and transferred to a glass autosampler vials to be
injected into the GC–NPD.
Optimization of the ASE procedure
The optimization of the ASE procedure was performed taking
into consideration the inﬂuence of the temperature, quantity
of static cycle and the best solvent on the extraction yield.
Method optimization was carried out on meconium samples
spiked with a known concentration of 100 ng/g of nicotine
and cotinine. The efﬁciency of extraction was assessed by the
absolute average chromatographic peak area produced by each
analyte in triplicate. The following parameters were studied:
temperature (80, 100, and 1208C); number of static cycles (1, 2
and 3) with each one lasting for 3 min; and choice of solvent
(hexane/acetone, 1:1, v/v and 0.1 M phosphate buffer, pH 6.0).
Validation of the method
The validation of the method was performed by establishing
limits of detection (LOD) and quantiﬁcation (LOQ), linearity,
intra- and interassay precision, and recovery values of the
analytes.
LOD and LOQ
The LOD and LOQ were determined by the empirical method
that consisted of analyzing a series of meconium samples con-
taining decreasing amounts of the nicotine and cotinine. The
LOD was the lowest concentration that presented an RSD that
did not exceed 20%, and the LOQ the lowest concentration
that presented an RSD that did not exceed 15% in six repli-
cates. LOD and LOQ should still satisfy the predetermined ac-
ceptance criteria of qualiﬁcation (retention time within 2%
compared with standards analyzed in the same batch). LOQ
should fall within +20% of the expected value (nominal
concentration).
Linearity
The study of linearity was established by the analyses of meco-
nium samples spiked in triplicate at the following concentra-
tions: 5, 10, 50, 100, 300, and 500 ng/g (for cotinine) and 40,
100, 200, 300, 400, and 500 ng/g (for nicotine). The relation-
ship between peak-area ratios (analyte/IS) and concentrations
of the analytes in the samples was determined by linear
regression.
Intra- and interassay precision
Imprecision, deﬁned as the relative standard deviation (RSD),
was determined by intra- and interday repetitions. They were
performed by analyzing meconium samples fortiﬁed with nico-
tine and cotinine at low, medium, and high concentrations on
three different days. The following concentrations were used in
the assays: cotinine (20, 250, and 400 ng/g) and nicotine (120,
250, and 400 ng/g). Six replicate analyses were performed at
each concentration.
Accuracy
The accuracy of the method was evaluated by analyzing, in trip-
licate, meconium samples spiked with nicotine and cotinine at
low, medium and high concentrations (the same concentra-
tions used in the precision test). The experimental concentra-
tions, quantiﬁed using the standard calibration curves, were
then expressed as a percentage [(mean measured concentra-
tion/nominal concentration)  100].
Recovery
The extraction efﬁciency of nicotine and cotinine was evalu-
ated through the recovery studies that were performed by pre-
paring two sets of samples of each concentration. One of them
(set A), consisting of three concentrations (the same concen-
trations used in the precision study: low, medium, and high),
was extracted using the method described in the Preparation
of meconium samples section. The analyses were performed
six times for each concentration. The other one (set B) also
consisted of six replicates of each concentration (low, medium,
and high). However, standard solutions of the analytes were
spiked to the extract immediately before drying under nitrogen
stream. To both sets (A and B), internal standard was added
Table I
Confidence Parameters of the Validated Method for the Determination of the Cotinine and
Nicotine in Meconium
Cotinine Nicotine
LOD 3 ng/g 30 ng/g
LOQ 5 ng/g 40 ng/g
Intraassay precision (RSD %)
CQ1* 10.2 11.9
CQ2 7.3 12.9
CQ3 4.7 7.7
Interassay precision (RSD %)
CQ1 20.1 13.0
CQ2 19.4 18.9
CQ3 6.4 4.3
Accuracy (%)
CQ1 95.1 96.0
CQ2 88.7 93.1
CQ3 92.5 96.8
Recovery (%)
CQ1 65 72
CQ2 76 85
CQ3 83 82
* CQ1 ¼ 20 ng/g cotinine and 120 ng/g nicotine; CQ2 ¼ 250 ng/g cotinine and 250 ng/g
nicotine; and CQ3 ¼ 400 ng/g cotinine and 400 ng/g nicotine.
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prior to the extraction of the matrix. The absolute recovery,
expressed as a percentage, was evaluated by comparison of the
mean response of extracted samples fortiﬁed before extraction
and the response of the extracted blank matrix samples to
which analytes had been added at the same concentration just
before the drying step.
Results and Discussion
Sample preparation
In general, the detection of drugs and metabolites in meco-
nium samples is extremely difﬁcult because of the high con-
centration of endogenous compounds such as lipids, proteins,
and salts and the low concentration of the analytes present in
the specimen. Currently published methods to extract sub-
stances from meconium for chromatographic analysis are gen-
erally time-consuming and laborious, often involving at least
two steps of sample preparation: homogenization of meconium
in a liquid prior to SPE for puriﬁcation of analytes (18).
In the last few years, few analytical methods were published
in the scientiﬁc literature for the detection of nicotine biomar-
kers in meconium samples. In one of the ﬁrst published
methods, Boranowski et al. (14) emulsiﬁed 2.0 g of sample with
20 mL of phosphate buffer (pH 6.0) and carried out an
extraction with chloroform. After the evaporation of the
extract, the residue was dissolved in buffer, and an SPE proced-
ure was used for puriﬁcation of analytes (nicotine, cotinine,
and caffeine), prior to liquid chromatographic (HPLC) analysis.
Ko¨hler et al. (6) used a modiﬁed method published by
Dempsey et al. (19) to assess prenatal tobacco smoke exposure.
In summary, the following procedure was conducted: meco-
nium (0.5 g) was homogenized with 3 mL of methanol and
alkaline-hydrolyzed under ultrasonic treatment for 30 min.
Following centrifugation the supernatant was evaporated and
reconstituted with buffer. Afterwards, the solution was submit-
ted to an SPE step. The analytes (nicotine, cotinine, and
trans-30-hydroxycotinine) were detected by HPLC. Gray et al.
(13) extracted nicotine biomarkers (nicotine, cotinine,
trans-30-hydroxycotinine, nornicotine, and norcotinine) from
meconium by using acidiﬁed methanol homogenization. After
centrifugation, the supernatant was evaporated and reconsti-
tuted with phosphate buffer for overnight enzymatic hydrolysis
(18 h). An SPE procedure of the solution was still necessary for
further detection of analytes by liquid chromatography–
tandem mass spectrometry (LC–MS–MS). More recently, Marin
et al. (20) detected nicotine and metabolites in paired umbil-
ical cord tissue and meconium samples using LC–MS–MS.
Preparation of samples also involved homogenization with
organic solvents and clean-up of extracts with SPE.
Figure 3. Chromatograms obtained with the ASE and GC–NPD analysis of a meconium samples. Sample spiked with nicotine (A) and cotinine (C) at concentration of 100 ng/g
and the internal standard prolintane (B) (I); blank meconium sample (II); and positive sample containing 55.3 ng/g of nicotine and 61.6 ng/g of cotinine (III).
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In the present work, ASE was used for the pretreatment of
meconium before the SPE step. The use of ASE technique
instead of organic solvent homogenization provided a simpler
and faster method because no evaporation step was necessary
prior the SPE procedure. Also, no organic solvent (chloroform
or methanol) was used for pretreatment of samples. Instead,
buffer solution could be used, because ASE works with a ﬁltra-
tion system that makes possible the direct use of the aqueous
extract to the subsequent SPE procedure. Because hydrolysis is
a lengthy and costly process, this procedure was not taken into
consideration in the present method. In addition, in a study
performed by Gray et al. (5), who analyzed 125 paired meco-
nium samples (with and without hydrolysis), they identiﬁed
only 1 additional positive specimen in the group of hydrolyzed
samples. The authors also veriﬁed that nicotine, cotinine, and
trans-30-hydroxycotinine are the most prevalent and abundant
biomarkers found in meconium of tobacco-exposed neonates.
Unfortunately, trans-30-hydroxycotinine standard was not com-
mercially available in Brazil to be included in our study.
Optimization of the ASE procedure
For the optimization of the ASE procedure, the inﬂuence of the
number of cycles in extraction efﬁciency was evaluated. The
number of static cycles can be selected to improve the efﬁ-
ciency of the extraction, whereas a longer contact time of
solvent with the sample could help in maintaining the balance
of the extraction. In practice, it was observed that one cycle
produced the highest efﬁciency of the extraction (Figure 2A).
Two solvent systems were evaluated in three different tem-
peratures of extraction (80, 100, and 1208C). The choice of the
mixture hexane/acetone (1:1) was based on the study of
Curwin et al. (21), who used this solvent system to extract
nicotine from wipes by means of the ASE technique. Phosphate
buffer (0.1 M, pH 6.0) was also tested because it would be
more practical to have an extract already dissolved in the same
solvent to be used in the next step of sample preparation
(SPE). Interestingly, although they have distinct physical-
chemical properties, both solvents system showed to have
similar efﬁciency in the extraction yield for the three tested
temperatures (Figures 2B and 2C). Nevertheless, organic sol-
vents have disadvantages when compared with aqueous solu-
tions because they are more toxic to the analyst and hazardous
to the environment. Therefore, phosphate buffer was chosen as
solvent to be used in the ASE system. The temperature of
1208C provided the best result for extraction of the analytes in
meconium.
Validation of the method
The conﬁdence parameters of the validated method (LOD,
LOQ, intra- and interassay precision, accuracy, and recovery)
for the determination of nicotine and cotinine in meconium
are shown in Table I.
Calibration curves were linear over the speciﬁed range
(LOQ–500 ng/g). The linear regression equations and coefﬁ-
cients of correlation were as follows: nicotine y ¼ 0.0144x –
0.5509; r2 ¼ 0.9872 and cotinine y ¼ 0.1400x þ 5.4319; r2 ¼
0.9901, where y and x represent the relationship between the
peak-area ratio (compound/internal standard) and the corre-
sponding calibration concentrations, respectively.
The method showed good linearity over a broad concentra-
tion range (LOQ–500 ng/g). Considering that meconium is a
complex matrix and the sample preparation consisted of two
extraction techniques, the precision was considered acceptable
over the studied concentration range (RSD , 15% for intraas-
says). The ASE procedure followed by SPE produced clean
extracts for GC–NPD analysis with good recovery (average
77.2%).
Method application
The developed method was applied to 16 meconium samples
collected from neonates whose mothers admitted using
tobacco during pregnancy. Samples were collected from neo-
nates who were born in the University Hospital of Sa˜o Paulo
(HU-USP). Figure 3 shows GC–NPD chromatograms obtained
with the practical use of this method to the analysis of meco-
nium samples [a sample fortiﬁed with 100 ng/g of analytes (I),
blank sample (II), and a positive sample containing 55.3 ng/g
of nicotine and 61.6 ng/g of cotinine (III)]. Table II shows the
results for 16 meconium samples analyzed by the ASE/SPE
method.
Conclusions
A GC–NPD screening method for the determination of coti-
nine and nicotine in meconium samples was developed.
Sample pretreatment was simpliﬁed using the accelerated
solvent extraction technique compared to previous published
chromatographic methods. Also, smaller volumes of organic sol-
vents were necessary. Taking into consideration that meconium
is a complex matrix the values of precision (RSD less than 15%
for intraassay precision) are acceptable. The method can be
readily used to evaluate tobacco exposure during pregnancy.
ASE can be a useful technique to be employed in the analysis
of complex biological samples.
Table II
Concentrations of Cotinine and Nicotine (ng/g) Detected in 16 Positive Meconium Samples
Analyzed by the Developed Method
ID Cotinine Nicotine
1 90.7 329.3
2 41.8 131.8
3 50.2 221.5
4 61.6 55.3
5 35.3 266.6
6 38.0 n.d.*
7 46.8 n.d.
8 58.5 194.5
9 34.1 195.8
10 30.9 133.2
11 45.5 175.4
12 49.0 234.0
13 31.8 113.9
14 34.4 141.6
15 53.1 195.1
16 32.0 180.8
* n.d. ¼ not detected
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